Neil Mehta, MD
Associate Professor
Medicine
School of Medicine

In his research, Mehta examines liver cancer treatment, particularly as related to liver transplants. He has contributed to important publications in this area. His other research interests include outcomes for patients who undergo liver transplantation and cardiac iron overload in patients with chronic liver disease. He frequently lectures in the community and at the university on these subjects.

At the UCSF School of Medicine, Mehta supervises the training of residents as well as fellows in both gastroenterology and liver transplant medicine. He also delivers lectures on liver disease to UCSF medical students studying metabolism and nutrition.

Mehta earned his medical degree at UCSF and completed a residency in internal medicine at the University of Pennsylvania. He completed fellowships in gastroenterology and liver transplantation at UCSF.

• Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
  Radiology 2023 Hassan OT, Behr SC, Ohliger MA, Fowler KJ, Gill RM, Fidelman N, Mehta N, Choi HH
• How I Approach Hepatocellular Adenomas in Hormonally Distinct Populations: Time to Think Outside the (Contraceptive Pill) Box.
  The American journal of gastroenterology 2023 Wang M, Cedars MI, Mehta N, Sarkar M
• AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
  Journal of hepatology 2023 Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N
• Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Wu X, Kwong A, Heller M, Lokken RP, Fidelman N, Mehta N
• Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma.
  Surgical oncology clinics of North America 2023 Yilma M, Mehta N
• Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Natarajan B, Tabrizian P, Hoteit M, Frenette C, Parikh N, Ghaziani T, Dhanasekaran R, Guy J, Shui A, Florman S, Yao FY, Mehta N
• Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.
  Annals of surgery 2023 Ivanics T, Claasen MPAW, Samstein B, Emond JC, Fox AN, Pomfret E, Pomposelli J, Tabrizian P, Florman SS, Mehta N, Roberts JP, Emamaullee JA, Genyk Y, Hernandez-Alejandro R, Tomiyama K, Sasaki K, …
• Community-level social vulnerability and individual socioeconomic status on liver transplant referral outcome.
  Hepatology communications 2023 Yilma M, Cogan R, Shui AM, Neuhaus JM, Light C, Braun H, Mehta N, Hirose R
• Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification.
  Current opinion in organ transplantation 2023 Norman J, Mehta N, Kwong A
• Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.
  JAMA network open 2023 Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K
• Geographic disparities in access to liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Yilma M, Dalal N, Wadhwani SI, Hirose R, Mehta N
• AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
  Hepatology (Baltimore, Md.) 2023 Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH
• Refining the approach to down-staging of HCC prior to liver transplantation: Patient selection, loco-regional treatments, and systemic therapies.
  Hepatology (Baltimore, Md.) 2023 Mehta N, Kelley RK, Yao FY
• AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY
• Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
  JHEP reports : innovation in hepatology 2023 Wu X, Lokken RP, Mehta N
• Resected Tumor Outcome and Recurrence (RESTORE) Index for Hepatocellular Carcinoma Recurrence after Resection.
  Cancers 2023 Hoffman D, Shui A, Gill R, Syed S, Mehta N
• Patient survey augments detection of harmful alcohol relapse after liver transplant for alcohol-associated cirrhosis.
  Hepatology communications 2023 Rice BA, Mehta N, Grab J, Dodge JL, Sherman CB
• Abstract No. 251 ? FEATURED ABSTRACT Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for Downstaging of Hepatocellular Carcinoma Before Liver Transplant.
  Journal of Vascular and Interventional Radiology 2023 X. Wu, A. Kwong, M. Heller, R. Lokken, N. Fidelman, N. Mehta
• Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study.
  Hepatology communications 2023 Singal AG, Ghaziani TT, Mehta N, Zhou K, Grinspan LT, Benhammou JN, Moon AM, Yang JD, Salgia R, Pillai A, Zheng E, Rich NE, Gopal P, Jalal P, Verna E, Yekkaluri S, Phen S, Melendez-Torres J, …
• Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates.
  Journal of vascular and interventional radiology : JVIR 2023 Wu X, Heller M, Kwong A, Fidelman N, Mehta N
• Outcomes after liver transplantation using deceased after circulatory death donors: A comparison of outcomes in the UK and the US.
  Liver international : official journal of the International Association for the Study of the Liver 2023 Ivanics T, Claasen MPAW, Patel MS, Giorgakis E, Khorsandi SE, Srinivasan P, Prachalias A, Menon K, Jassem W, Cortes M, Sayed BA, Mathur AK, Walker K, Taylor R, Heaton N, Mehta N, Segev DL, Massie AB, …
• Number of Local Regional Therapies for Hepatocellular Carcinoma and Peri-Operative Outcomes after Liver Transplantation.
  Cancers 2023 Brown AE, Shui AM, Adelmann D, Mehta N, Roll GR, Hirose R, Syed SM
• Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Giard JM, Dodge JL, Yao FY, Mehta N
• Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.
  Contraception 2022 Qureshy Z, Lokken RP, Kakar S, Grab J, Mehta N, Sarkar M
• An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma.
  Gastroenterology research 2022 Wong RJ, Jayasekera C, Jones P, Kanwal F, Singal AG, Ahmed A, Taglienti R, Younossi Z, Kulik L, Mehta N
• Now you see it, now you don't: Estrogen exposure and obesity effects on HCA development and regression.
  Hepatology (Baltimore, Md.) 2022 Wang M, Sarkar M, Mehta N
• Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada.
  Journal of hepatology 2022 Ivanics T, Wallace D, Claasen MPAW, Patel MS, Brahmbhatt R, Shwaartz C, Prachalias A, Srinivasan P, Jassem W, Heaton N, Cattral MS, Selzner N, Ghanekar A, Morgenshtern G, Mehta N, Massie AB, van der …
• Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
  JAMA surgery 2022 Tabrizian P, Holzner ML, Mehta N, Halazun K, Agopian VG, Yao F, Busuttil RW, Roberts J, Emond JC, Samstein B, Brown RS, Najjar M, Chapman WC, Doyle MM, Florman SS, Schwartz ME, Llovet JM
• National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Huang AC, Dodge JL, Yao FY, Mehta N
• Liver allocation policies for hepatocellular carcinoma have leveled the playing field-But who should be playing?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Kwong AJ, Mehta N
• Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2022 Bernards S, Lee E, Leung N, Akan M, Gan K, Zhao H, Sarkar M, Tayur S, Mehta N
• Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
  Cancer 2022 Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen…
• Abstract No. 261 Cost-effectiveness analysis of interventional liver-directed therapies for a single, small (< 3 cm) hepatocellular carcinoma in liver transplant candidates.
  Journal of Vascular and Interventional Radiology 2022 X. Wu, M. Heller, A. Kwong, N. Fidelman, N. Mehta
• Nodular Regenerative Hyperplasia After Liver Transplant; It's All in the Presentation.
  Frontiers in surgery 2022 Chen AK, Lunow-Luke T, Yamaguchi S, Praglin C, Agudelo E, Mehta N, Dirks R, Braun HJ, Gardner JM, Roberts JP, Syed SM, Roll GR
• 531: DEVELOPMENT AND VALIDATION OF A RISK SCORE FOR PREDICTING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B WITHIN A LARGE, REPRESENTATIVE, NORTHERN CALIFORNIA COHORT.
  Gastroenterology 2022 Varun Saxena, Liyan Liu, Joanna B. Ready, Mai Sedki, Krisna P. Chai, Suk I. Seo, Nizar A. Mukhtar, Sreepriya Balasubramanian, Brock A. Macdonald, Neil Mehta, Julie A. Schmittdiel
• EP1003: EVALUATION OF SOCIOECONOMIC STATUS WITHIN HOTSPOTS OF HEPATOCELLULAR CARCINOMA AMONG A LARGE DIVERSE PATIENT COHORT IN NORTHERN CALIFORNIA.
  Gastroenterology 2022 Mignote Yilma, Jackson Voelkel, Richie Houhong Xu, Leu-Yen Tucker, Monica Muzzin, Varun Saxena, Neil Mehta, Jeffrey K. Lee, Suk I. Seo, Brock A. Macdonald, Joanna B. Ready, Sreepriya Balasubramanian, …
• National experience with living donor liver transplantation for hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Silverstein J, Yao FY, Grab JD, Braun HJ, Roberts J, Dodge JL, Mehta N
• Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma.
  Cancer medicine 2022 Kwong A, Hameed B, Syed S, Ho R, Mard H, Arshad S, Ho I, Suleman T, Yao F, Mehta N
• Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Goldman ML, Zhou K, Dodge JL, Yao F, Mehta N
• Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis.
  Current gastroenterology reports 2022 Yilma M, Saxena V, Mehta N
• Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
  Hepatology (Baltimore, Md.) 2021 Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D…
• National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors.
  The British journal of surgery 2021 Wallace D, Cowling TE, Suddle A, Gimson A, Rowe I, Callaghan C, Sapisochin G, Ivanics T, Claasen M, Mehta N, Heaton N, van der Meulen J, Walker K
• Decreased Urgency Among Liver Transplantation Candidates With Hepatocellular Carcinoma in the United States.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Kwong AJ, Ghaziani TT, Mehta N
• The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Bernards S, Hirose R, Yao FY, Jin C, Dodge JL, Huang CY, Mehta N
• Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016.
  Transplantation 2021 Ivanics T, Wallace D, Abreu P, Claasen MPAW, Callaghan C, Cowling T, Walker K, Heaton N, Mehta N, Sapisochin G, van der Meulen J
• Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
  Transplantation 2021 Cullaro G, Rubin J, Mehta N, Yao F, Verna EC, Lai JC
• Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Mehta N, Yao FY
• Liver transplantation for HCC: validation of prognostic power of the RETREAT score for recurrence in a UK cohort.
  HPB : the official journal of the International Hepato Pancreato Biliary Association 2021 Reddy SHS, Mehta N, Dodge JL, Hakeem AR, Khorsandi SE, Jassem W, Vilca-Melendez H, Cortes-Cerisuelo M, Srinivasan P, Prachalias A, Heneghan MA, Aluvihare V, Suddle A, Miquel R, Rela M, Heaton ND, …
• National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Kwong AJ, Ghaziani TT, Yao F, Sze D, Mannalithara A, Mehta N
• Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
  Gastroenterology 2021 Mehta N, Frenette C, Tabrizian P, Hoteit M, Guy J, Parikh N, Ghaziani TT, Dhanasekaran R, Dodge JL, Natarajan B, Holzner ML, Frankul L, Chan W, Fobar A, Florman S, Yao FY
• Liver Transplantation Criteria for Hepatocellular Carcinoma, Including Posttransplant Management.
  Clinical liver disease 2021 Mehta N
• Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
  JAMA surgery 2021 Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, Brar G, Sasaki K, Doyle MBM, Tabrizian P, Agopian VG, Najjar M, Ivanics T, Samstein B, Brown RS, Emond JC, Yao F, Lerut J, Rossi M…
• Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021 Harding-Theobald E, Yao FYK, Mehta N
• 433 THE ASSOCIATION OF SUSTAINED VIROLOGIC RESPONSE ON TREATMENT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH HEPATITIS C.
  Gastroenterology 2021 Neehar D. Parikh, Neil Mehta, Maarouf Hoteit, Ju Dong Yang, Binu V. John, Andrew M. Moon, Reena Salgia, Anjana A. Pillai, Ihab Kassab, Naba Saeed, Emil Thyssen, Piyush Nithani, Jeffrey Mckinney, …
• Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
  AJR. American journal of roentgenology 2021 Lokken RP, Kerlan RK, Chung YC, Chen YF, Mehta NJ, Yao FY, Fidelman N
• DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Kotwani P, Chan W, Yao F, Mehta N
• The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
  Seminars in liver disease 2021 Yao FY, Fidelman N, Mehta N
• Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, …
• Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
  Digestive diseases and sciences 2020 Deng LX, Mehta N
• Reply.
  Hepatology (Baltimore, Md.) 2020 Mehta N, Yao FY
• Opioid use prior to liver transplant is associated with increased risk of death after transplant.
  American journal of surgery 2020 Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL
• A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
  Journal of hepatology 2020 Mehta N, Dodge JL, Roberts JP, Yao FY
• Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse.
  Current Hepatology Reports 2020 Varun Saxena, Neil Mehta
• COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
  Transplantation 2020 Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C
• Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
  Hepatology (Baltimore, Md.) 2020 Rich NE, John BV, Parikh ND, Rowe I, Mehta N, Khatri G, Thomas SM, Anis M, Mendiratta-Lala M, Hernandez C, Odewole M, Sundaram LT, Konjeti VR, Shetty S, Shah T, Zhu H, Yopp AC, Hoshida Y, Yao FY, …
• Social Media as an Early Proxy for Social Distancing Indicated by the COVID-19 Reproduction Number: Observational Study.
  JMIR public health and surveillance 2020 Younis J, Freitag H, Ruthberg JS, Romanes JP, Nielsen C, Mehta N
• Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma: Is There a Limit?
  Clinics in liver disease 2020 Kwong A, Mehta N
• Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival.
  Transplantation 2020 Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM
• The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study.
  Transplantation 2020 Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G
• Recurrence of hepatocellular carcinoma following liver transplantation.
  Expert review of gastroenterology & hepatology 2020 Hoffman D, Mehta N
• Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma.
  Transplantation direct 2020 Weinfurtner K, Dodge JL, Yao FYK, Mehta N
• Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, …
• Downstaging to Liver Transplant: Success Involves Choosing the Right Patient.
  Clinics in liver disease 2020 Zhou K, Mehta N
• Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
  JAMA cardiology 2020 Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK
• OPIOID USE PRIOR TO LIVER TRANSPLANT IS ASSOCIATED WITH INCREASED RISK OF DEATH AFTER TRANSPLANT.
  Transplantation 2020 Hillary Braun, Marisa P. Schwab, Chengshi Jin, Dominic Amara, Trevor Grace, Rhiannon Croci, Chris E. Freise, John P. Roberts, Neil Mehta, Ryutaro Hirose, Nancy L. Ascher
• Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19.
  Circulation. Cardiovascular quality and outcomes 2020 Kalra A, Hawkins ES, Nowacki AS, Jain V, Milinovich A, Saef J, Thomas G, Gebreselassie SK, Karnik SS, Jehi L, Young JB, Svensson LG, Chung MK, Mehta N
• SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy.
  EBioMedicine 2020 Chung MK, Karnik S, Saef J, Bergmann C, Barnard J, Lederman MM, Tilton J, Cheng F, Harding CV, Young JB, Mehta N, Cameron SJ, McCrae KR, Schmaier AH, Smith JD, Kalra A, Gebreselassie SK, Thomas G, …
• THU248 Re-establishing abstinence after alcohol relapse after early transplant (LT) for alcoholic hepatitis (AH) provides survival advantage.
  Journal of Hepatology 2020 George Therapondos, Brian Lee, Gene Im, John Rice, Ann Lazar, Michael R. Lucey, Ethan Weinberg, Hyosun Han, Haripriya Maddur, R. Mark Ghobrial, Christine Hsu, Oren Fix, Sheila Eswaran, Kirti Shetty, …
• Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020 Silverstein J, Roll G, Dodge JL, Grab JD, Yao FY, Mehta N
• Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Mehta N, Parikh ND, Kelley RK, Hameed B, Singal AG
• Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic.
  JAMA network open 2020 Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, Nowacki AS, Shah R, Khubber S, Kanaa'N A, Hedrick DP, Sleik KM, Mehta N, Chung MK, Khot UN, Kapadia SR, Puri R, Reed GW
• Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
  Transplantation 2020 Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A
• Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma.
  Transplantation 2020 Lee E, Sarkar M, Dodge J, Kohi M, Mehta N
• Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020 Brondfield MN, Dodge JL, Hirose R, Heimbach J, Yao FY, Mehta N
• Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study.
  Transplant international : official journal of the European Society for Organ Transplantation 2020 Assalino M, Terraz S, Grat M, Lai Q, Vachharajani N, Gringeri E, Bongini MA, Kulik L, Tabrizian P, Agopian V, Mehta N, Brustia R, Vitali GC, Andres A, Berney T, Mazzaferro V, Compagnon P, Majno P, …
• Hepatocellular Carcinoma-How to Determine Therapeutic Options.
  Hepatology communications 2020 Mehta N
• Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Cullaro G, Rubin JB, Mehta N, Lai JC
• National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Grab JD, Yao FY
• REPLY.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Yao FY
• Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
  JAMA network open 2019 Gutin L, Yao F, Dodge JL, Grab J, Mehta N
• Using Standardized Checklists Increase the Completion Rate of Critical Actions in an Evacuation from the Operating Room: A Randomized Controlled Simulation Study.
  Prehospital and disaster medicine 2019 Acar YA, Mehta N, Rich MA, Yilmaz BK, Careskey M, Generoso J, Fidler R, Hirsch J
• Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
  Gastroenterology 2019 Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, …
• Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran …
• Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol.
  Hepatology (Baltimore, Md.) 2019 Sinha J, Mehta N, Dodge JL, Poltavskiy E, Roberts J, Yao F
• Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY
• PS-206-Patterns and predictors of alcohol use after early liver transplant for alcoholic hepatitis.
  Journal of Hepatology 2019 Brian Lee, Mary Rinella, Gene Im, John Rice, Oren Fix, George Therapondos, Hyosun Han, David Victor, Ethan Weinberg, Cristine Hsu, Michael Voigt, Haripriya Maddur, Sheila Eswaran, David Foley, R. Mark…
• A Curriculum for Diagnostic Reasoning: JGIM's Exercises in Clinical Reasoning.
  Journal of general internal medicine 2019 Subramanian A, Connor DM, Berger G, Lessing JN, Mehta N, Manesh R, Kohlwes J
• What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?
  Clinical liver disease 2019 Mehta N, Yao FY
• Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
  Hepatology (Baltimore, Md.) 2019 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Sherman CB, Behr S, Dodge JL, Roberts JP, Yao FY, Mehta N
• The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM
• Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
  Gastroenterology 2019 Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, …
• Screening for Hepatocellular Carcinoma to Improve Cancer-Related Mortality: Looking Behind When We Should Be Looking Ahead.
  Gastroenterology 2018 Mehta N, Monto A, Yao FY
• Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
  HPB : the official journal of the International Hepato Pancreato Biliary Association 2018 Goldaracena N, Mehta N, Scalera I, Sposito C, Atenafu EG, Yao FY, Muiesan P, Mazzaferro V, Sapisochin G
• Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY
• Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Samoylova ML, Mehta N, Roberts JP, Yao FY
• A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence.
  The American journal of surgical pathology 2018 Roberts DE, Kakar S, Mehta N, Gill RM
• Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes.
  Transplantation direct 2018 Lewin SM, Kallianos K, Nevah MI, Zhao S, Fix OK, Brooks GC, De Marco T, Qasim AN, Ordovas KG, Mehta N
• Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
  Hepatology (Baltimore, Md.) 2018 Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA
• Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
  Transplantation 2018 Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY
• Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
  Gastroenterology 2018 Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, …
• Abstract No. 522 Outcomes of TACE for hepatocellular carcinoma in patients with HIV infection.
  Journal of Vascular and Interventional Radiology 2018 E. Phillips, R. Kohlbrenner, A. True-Yasaki, N. Fidelman, A. Taylor, E. Lehrman, M. Kohi, K. Kolli, R. Kerlan, N. Mehta
• Abstract No. 525 Liver transplantation rates for hepatocellular carcinoma: is there a sex-related difference?.
  Journal of Vascular and Interventional Radiology 2018 M. Kohi, M. Sarka, J. Dodge, J. Roberts, N. Terrault, N. Mehta
• Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
  Transplantation 2018 Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G
• SAT-448 Higher early post-liver transplant mortality in recipients with severe alcoholic hepatitis versus alcoholic cirrhosis.
  Journal of Hepatology 2018 B. Lee, G. Im, J. Dodge, M. Voigt, J. Rice, M.R. Lucey, D. Foley, L. Platt, A. Gurakar, N. Mehta, G. Therapondos, H. Han, D. Victor, O. Fix, L. Dinges, D. Dronamraju, C. Hsu, M. Rinella, H. Maddur, S.…
• Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Mehta N, Yao FY
• Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels.
  Hepatology communications 2018 Azeem N, Ajmera V, Hameed B, Mehta N
• Interventions to improve the mechanical ventilation fidelity of the Laerdal SimMan® 3G simulation mannequin.
  Canadian journal of anaesthesia = Journal canadien d'anesthesie 2017 Mehta NJ, Latoures R, Stechert MM, Fidler RL, Hirsch J
• Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 Mehta N, Dodge JL, Roberts JP, Yao FY
• Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017 Mehta N, Yao FY
• International Differences in the Risk of Death from Smoking and Obesity: The Case of the United States and Finland.
  SSM - population health 2017 Mehta N, Elo I, Stenholm S, Aromaa A, Heliövaara M, Koskinen S
• Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017 Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY
• Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.
  Clinical transplantation 2017 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
  Transplantation 2017 Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY
• Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017 Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D
• Acute liver injury in a Glatopa-treated patient with MS.
  Neurology(R) neuroimmunology & neuroinflammation 2017 Sabatino JJ, Mehta NJ, Kakar S, Zamvil SS, Cree BAC
• Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
  Transplantation 2017 Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC
• Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
  JAMA oncology 2017 Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY
• Screening for hepatocellular carcinoma: What is missing?
  Hepatology communications 2016 Mehta NJ, Celik AD, Peters MG
• Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?
  Gastroenterology 2016 Mehta N, Yao FY
• Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.
  Hepatology (Baltimore, Md.) 2016 Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, …
• Reply.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Yao FY
• Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
  Annals of hepatology 2016 Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N
• Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Roberts JP, Yao FY
• Immigrant status and cardiovascular risk over time: results from the Multi-Ethnic Study of Atherosclerosis.
  Annals of epidemiology 2016 Lê-Scherban F, Albrecht SS, Bertoni A, Kandula N, Mehta N, Diez Roux AV
• HCC recurrence following liver tranplantation should be aggresively treated to increase patient survival.
  Hepato Pancreato Biliary 2016 G. Sapisochin, N. Mehta, I. Scalera, C. Sposito, F.Y. Yao, P. Muiesan, V. Mazzaferro, D.R. Grant
• Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan.
  Current opinion in organ transplantation 2016 Mehta N, Yao FY
• “Very early” intrahepatic cholangiocarcinoma may become an acceptable indication for liver transplantation. A multicenter validation study.
  Hepato Pancreato Biliary 2016 G. Sapisochin, M. Facciuto, N. Mehta, E. Vibert, R. Hernandez-Alejandro, A.D. Pinna, S. Hwang, V.G. Agopian, G. Gores, J. Reyes, O. Soubrane, T. Reichman, P. Kim, C. Sposito, P.A. Clavien, C. Toso, N.…
• Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?
  Hepatology (Baltimore, Md.) 2016 Mehta N, Yao FY
• Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016 Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY
• Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
  Gastroenterology 2015 Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY
• Abstract 19009: The Association Between Clinical and Echocardiographic Imaging Findings and T2* in End Stage Liver Disease.
  Circulation 2015 Gabriel Brooks, Kathryn Brown, Neil Mehta, Karen Ordovas, Nevah Rubin, Elyse Foster, Atif Qasim
• Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
  Hepatology (Baltimore, Md.) 2015 Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP
• Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
  Clinical transplantation 2014 Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP
• Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N
• Response to letter to the editors.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Yao FY, Hameed B, Mehta N, Roberts JP
• Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY
• Should Hepatocellular Carcinoma Patients With Multiple Tumors <2cm Be Transplanted?.
  Transplantation Journal 2014 M. Samoylova, J. Dodge, F. Yao, N. Mehta, J. Roberts
• Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014 Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
• BMJ endgames: a new web-based BMJ/JGIM collaboration.
  Journal of general internal medicine 2014 Srinivasan M, Mehta N
• Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY
• Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation.
  JIMD reports 2013 Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, Ralph J
• Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Mehta N, Yao FY
• Reply: To PMID 23333661.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013 Yao F, Mehta N
• Immunosuppression: Conventions and controversies.
  Clinical liver disease 2013 Mehta N, Hirose R
• Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013 Mehta N, Fidelman N, Sarkar M, Yao FY
• 1016 Risk of Hepatic Artery and Biliary Complications in Liver Transplant Recipients Treated With Transarterial Chemoembolization.
  Gastroenterology 2012 Neil Mehta, Aparna Goel, Karen C. Bagatelos, James L. Buxbaum, Nicholas Fidelman, John P. Roberts, Norah A. Terrault, Francis Yao, James W. Ostroff
• Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy.
  Journal of clinical gastroenterology 2010 Miller J, Mehta N, Feldman M, Furth E, Ginsberg GG, Yang YX, Lewis JD
• Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
  International journal of oncology 2004 Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR